Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by N0taP00pon Sep 20, 2023 3:55pm
248 Views
Post# 35646052

RE:Financial Advisor

RE:Financial AdvisorI think we can all relate to that feeling, Camp. Sometimes, we invest based on an Initial conviction and then double down based on a combination of emotional attachment, hope and company statements that implied success is just around the corner.  Till it wasn't and we saw more delays and dilution. I thought Q1 of this year was going to to be our time, till it became Q1 of next year. I've only had one 10X (1000%) success story and many others where I sold early.  Right now, I'm holding because I like the data and feels like we're almost there. If we get BTD, I'm assuming a 10X-15X in maybe 3 to 6 months, with higher probability of a JV.  Unless there's a a big unknown hiccup, I don't see how the FDA can deny BTD.  But we've seen that movie before.  Keeping fingers crossed.   I'm hoping it's going to be more than a BTD ie. given the safety profile and efficacy and CR rate, why not an AA or an authorization to use as a combo treatment, even before BCG?  The BCG shortage is not getting any better and this treatment works and safe to boot.  I know it's all hopium at this point but that's what I'm using to stay sane.
Camphikefish wrote: While we wait. I had a brief conference with my investment advisor today and he questioned why I'd be invested in a biotech penny stock for over 10 years when my money could've tripled in the overall market. Of course I mentioned our unique science, efficacy, patient population, BTD, and the whole 9 yards as we say in the states. He briefly made me feel as if I must be financially immature, poorly informed, and misguided. There is no overall point here I'm mostly just sharing the empty pit I felt in my stomach for a minute. I wonder if any of you have felt the same? I told him we'd see who has the last laugh. Hopefully I've not been living in fantasyland for over a decade! I still believe we get to at least $5-10 eventually. Getting older! Let's go 1433 and take us to the finish line! 


<< Previous
Bullboard Posts
Next >>